PROCW
Procaps Group, S.A.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · LU
$0.02
+33.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.04x
- PEG TTM
- —
- Price / book
- 0.05x
- Price / sales
- 0.00x
- Price / cash flow
- 0.03x
Enterprise value
- Enterprise value
- $273.4M
- EV / sales
- 0.66x
- EV / EBITDA
- 2.27x
- EV / EBIT
- 2.92x
- Market cap
- $2.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2023